Similar drugs approved for use in Hong Kong earlier, including Novo Nordisk’s Ozempic, use semaglutide as their main ...

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

A new stronger Ozempic is coming. Here’s what to knowNovo Nordisk (NVO) teased some new details about a potential Ozempic ...

Customs and Border Protection agents in Cincinnati have seized shipments of unapproved weight loss drugs arriving from ...

Semaglutide remains on the agency’s drug shortage list, but all FDA-approved forms of the drug are no longer labeled ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in overweight patients with cardiovascular disease.

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

A retrospective cohort study using data from patients in 21 countries showed use of semaglutide use was not linked to an ...